Akcea Therapeutics Inc. (AKCA) Slipped -6.73% or -1.95 To Price $27.04 On Wednesday


Akcea Therapeutics Inc. (AKCA) slipped -6.73% or -1.95 to $27.04. It is nearly 195477 shares traded, which is 78.72% compare to the average total volume 248333. The market cap of AKCA is $2.42 billion. The year to date change is -12.39%. The 52 week price range is from $17.74 to $40.75. Price of AKCA have changed -6.57% during last week. It have changed -3.75% over last month, -5.39% over last 3 months, 16.71% over last 6 months and 29.59% over one year.

Some investors will use 50-day and 200-day Moving Averages as support and resistance levels. Those moving average will be very helpful most of time. The 50-day Moving Averages for AKCA is 29.09. It is 7.58% above current price. The 200-day Moving Averages for AKCA is 29.13. It is 7.73% above current price. The 52-week High is 40.75. It is 50.70% from the current price. The 52-week Low is 17.74. It is -34.39% from current price.

There are some statistics of AKCA. It is has market cap $2.42 billion. The share outstanding is 89.43 million. The average volume is 248333. The percent of top 15 Institution holding is 62.80%. Return on equity is how much of net income returned as a percentage of the total amount of shareholder equity found on the balance sheet. Return on equity (ROE) of AKCA is -103.26%. Return on assets (ROA) is an indicator that shows how profitable a company is using its total assets to generate earnings. Return on Assets (ROA) of AKCA is -72.54%.


Tags:

Share this post